Allarity Therapeutics, Inc. (ALLR)
NASDAQ: ALLR · Real-Time Price · USD
1.160
+0.030 (2.65%)
At close: Apr 2, 2026, 4:00 PM EDT
1.140
-0.020 (-1.72%)
After-hours: Apr 2, 2026, 6:49 PM EDT
Allarity Therapeutics Stock Forecast
Stock Price Forecast
The 1 analyst with a 12-month price forecast for Allarity Therapeutics stock has a target of 9.50, which predicts a 718.97% increase from the current stock price of 1.16.
Price Target: $9.50 (+718.97%)
Analyst Consensus: Strong Buy
* Price targets were last updated on Dec 9, 2025.
Analyst Ratings
According to 1 stock analyst, the rating for Allarity Therapeutics is "Strong Buy". This means that the analyst believes this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Nov '25 | Dec '25 | Jan '26 | Feb '26 | Mar '26 | Apr '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 1 | 1 | 1 | 1 | 1 | 1 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 1 | 1 | 1 | 1 | 1 | 1 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Ascendiant Capital | Ascendiant Capital | Strong Buy Maintains $9.25 → $9.5 | Strong Buy | Maintains | $9.25 → $9.5 | +718.97% | Dec 9, 2025 |
| Ascendiant Capital | Ascendiant Capital | Strong Buy Maintains $9 → $9.25 | Strong Buy | Maintains | $9 → $9.25 | +697.41% | Sep 26, 2025 |
| Ascendiant Capital | Ascendiant Capital | Strong Buy Initiates $9 | Strong Buy | Initiates | $9 | +675.86% | Jul 28, 2025 |
| Ladenburg Thalmann | Ladenburg Thalmann | Strong Buy → Hold Downgrades n/a | Strong Buy → Hold | Downgrades | n/a | n/a | Aug 23, 2022 |
| Ladenburg Thalmann | Ladenburg Thalmann | Strong Buy Initiates $6,720,000 | Strong Buy | Initiates | $6,720,000 | +579,310,244.83% | May 27, 2022 |
Financial Forecast
Revenue This Year
n/a
from 320.00K
Revenue Next Year
8.76M
EPS This Year
-0.99
from -0.78
EPS Next Year
-25.70
from -0.99
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2026 | 2027 |
|---|---|---|
| High | n/a | 9.0M |
| Avg | n/a | 8.8M |
| Low | n/a | 8.4M |
Revenue Growth
| Revenue Growth | 2026 | 2027 |
|---|---|---|
| High | - | - |
| Avg | - | - |
| Low | - | - |
EPS Forecast
| EPS | 2026 | 2027 |
|---|---|---|
| High | -1.02 | -26.46 |
| Avg | -0.99 | -25.70 |
| Low | -0.95 | -24.70 |
EPS Growth
| EPS Growth | 2026 | 2027 |
|---|---|---|
| High | - | - |
| Avg | - | - |
| Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.